Squarepoint Ops LLC Chimerix Inc Transaction History

Squarepoint Ops LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.1 - $1.54 $60,401 - $84,561	54,910 New	54,910 $66,000
Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $84,469 - $115,964	-16,151 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.75 $95,936 - $141,321	16,151 New	16,151 $100,000
Q3 2020 Nov 16, 2020	SELL	$2.3 - $3.72 $88,131 - $142,542	-38,318 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.33 - $3.63 $3,677 - $10,036	2,765 Added 7.78%	38,318 $119,000
Q1 2020 May 15, 2020	SELL	$1.27 - $2.33 $19,465 - $35,711	-15,327 Reduced 30.12%	35,553 $51,000
Q4 2019 Feb 14, 2020	BUY	$1.3 - $2.72 $66,144 - $138,393	50,880 New	50,880 $103,000
Q2 2019 Aug 14, 2019	SELL	$2.05 - $4.32 $334,209 - $704,285	-163,029 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.79 - $3.12 $186,793 - $325,584	104,354 Added 177.85%	163,029 $342,000
Q4 2018 Feb 14, 2019	SELL	$2.24 - $3.9 $30,824 - $53,667	-13,761 Reduced 19.0%	58,675 $151,000
Q3 2018 Nov 14, 2018	BUY	$3.58 - $4.9 $22,557 - $30,874	6,301 Added 9.53%	72,436 $282,000
Q2 2018 Aug 14, 2018	BUY	$4.43 - $5.14 $63,087 - $73,198	14,241 Added 27.44%	66,135 $315,000
Q1 2018 May 15, 2018	BUY	$4.65 - $5.9 $82,528 - $104,713	17,748 Added 51.98%	51,894 $270,000
Q4 2017 Feb 14, 2018	BUY	$4.32 - $5.52 $147,510 - $188,485	34,146	34,146 $158,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.